Novel Agent Reduces Bowel Movement Frequency in Carcinoid Syndrome

Fibrosis and carcinoid syndrome: from causation to future therapy

Gastrointestinal Neuroendocrine Tumors and the Carcinoid Syndrome - Endotext - NCBI Bookshelf

Novel Agent Reduces Bowel Movement Frequency in Carcinoid Syndrome

PDF) Carcinoid Syndrome and Hyperinsulinemic Hypoglycemia Associated with Neuroendocrine Neoplasms: A Critical Review on Clinical and Pharmacological Management

Total reduction in BM frequency with telotristat ethyl. (A

Cancers, Free Full-Text

Carcinoid Tumors and Syndrome

PDF) Understanding the Patient Experience with Carcinoid Syndrome: Exit Interviews from a Randomized, Placebo-Controlled Study of Telotristat Ethyl

Differential diagnosis of diarrhoea in patients with neuroendocrine tumours: A systematic review

Neuroendocrine neoplasms of the lung and gastrointestinal system: convergent biology and a path to better therapies

PDF) Life-threatening diarrhea in neuroendocrine tumors: two case reports